|
RELA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.639500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.203300E-04 |
| Normal-vs-Stage2 |
4.829600E-01 |
| Normal-vs-Stage3 |
4.903300E-03 |
| Normal-vs-Stage4 |
1.233010E-04 |
| Stage1-vs-Stage2 |
1.066630E-01 |
| Stage1-vs-Stage3 |
9.773400E-01 |
| Stage1-vs-Stage4 |
2.009800E-01 |
| Stage2-vs-Stage3 |
1.643800E-01 |
| Stage2-vs-Stage4 |
2.735600E-02 |
| Stage3-vs-Stage4 |
2.320600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44529999999999E-05 |
| Normal-vs-AfricanAmerican |
2.841600E-03 |
| Normal-vs-Asian |
4.984700E-04 |
| Caucasian-vs-AfricanAmerican |
2.592200E-01 |
| Caucasian-vs-Asian |
2.501800E-01 |
| AfricanAmerican-vs-Asian |
8.384800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.668300E-02 |
| Normal-vs-Female |
2.223700E-04 |
| Male-vs-Female |
3.683200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.603900E-04 |
| Normal-vs-Age(41-60Yrs) |
9.816800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.458410E-01 |
| Normal-vs-Age(81-100Yrs) |
1.161440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.038000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.860200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.117800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.678000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.877200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.006200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.951200E-01 |
| Classical-VS-Follicular |
8.04145638966247E-12 |
| Classical-VS-Other |
7.349900E-02 |
| Classical-VS-Normal |
1.71790000003114E-07 |
| Tall-VS-Follicular |
7.67450003547054E-09 |
| Tall-VS-Other |
2.378100E-02 |
| Tall-VS-Normal |
4.71440000004986E-06 |
| Follicular-VS-Other |
4.181000E-01 |
| Follicular-VS-Normal |
4.133900E-02 |
| Other-VS-Normal |
9.590400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.123700E-02 |
| Normal-vs-N1 |
1.489860E-02 |
| N0-vs-N1 |
3.429800E-01 |
|
|
